According to Agile Therapeutics 's latest financial reports the company's total assets are $10.88 M. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2022-12-31 | $14.24 M | -63.79% |
2021-12-31 | $39.33 M | -46.16% |
2020-12-31 | $73.06 M | 47.48% |
2019-12-31 | $49.54 M | 121.24% |
2018-12-31 | $22.39 M | -55.74% |
2017-12-31 | $50.59 M | -20.78% |
2016-12-31 | $63.86 M | 26.67% |
2015-12-31 | $50.42 M | -8.03% |
2014-12-31 | $54.82 M | 280.6% |
2013-12-31 | $14.4 M | -47.65% |
2012-12-31 | $27.51 M |
Company | Total assets | differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $167.55 B | 1,538,682.26% | ๐บ๐ธ USA |
Pfizer PFE | $226.50 B | 2,079,990.00% | ๐บ๐ธ USA |
Merck MRK | $106.67 B | 979,558.37% | ๐บ๐ธ USA |
TherapeuticsMD TXMD | $50.49 M | 363.71% | ๐บ๐ธ USA |
Antares Pharma ATRS | N/A | N/A | ๐บ๐ธ USA |